IPP Bureau
Symeres and Ambagon team up to target ‘undruggable’ proteins in colorectal cancer
By IPP Bureau - April 07, 2026
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk
By IPP Bureau - April 07, 2026
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Fischer Medical converts warrants into equity, infuses Rs 10.53 crore
By IPP Bureau - April 07, 2026
Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure
Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar
By IPP Bureau - April 07, 2026
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
HRV Pharma, Shodhana join hands to build next-gen API pipeline for global markets
By IPP Bureau - April 07, 2026
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
MedGenome’s RNA-based NGS study sharpens sarcoma diagnosis, alters treatment in 25% cases
By IPP Bureau - April 07, 2026
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
Lupin secures global Great Place To Work certification for 2026-27
By IPP Bureau - April 07, 2026
Recognition across subsidiaries and geographies highlights pharma major’s focus on inclusive culture, employee experience, and global workforce development
Alembic Pharma wins USFDA nod for generic Dapagliflozin, secures 180-day exclusivity
By IPP Bureau - April 07, 2026
Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.
Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians
By IPP Bureau - April 07, 2026
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Apollo report warns India’s silent health risks are striking earlier among young adults
By IPP Bureau - April 07, 2026
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
Practo reports surge in lifestyle disease awareness within Tier 2 cities, led by metabolic health searches
By IPP Bureau - April 07, 2026
Searches for diabetes, heart conditions, and metabolism-related risks are rising sharply, with Tier 2 cities outpacing metros in specialist consultations
AstraZeneca India, Telangana Govt partner for AI-led lung cancer screening in public hospitals
By IPP Bureau - April 07, 2026
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore
By IPP Bureau - April 07, 2026
The last-mile healthcare delivery across 1,100 villages, with focus on maternal health, diagnostics, and chronic disease management
SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education
By IPP Bureau - April 06, 2026
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Dharmendra Singh Gangwar appointed CEO of Rajiv Gandhi Cancer Institute
By IPP Bureau - April 06, 2026
Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation
